Argatroban in Sodium Chloride Injection 50 mg/50 mL (RX)

Argatroban in Sodium Chloride Injection 50 mg/50 mL is a medication used to prevent blood clots in patients who have medical conditions such as heparin-induced thrombocytopenia or HIT. It is a sterile solution containing argatroban, a direct thrombin inhibitor, and sodium chloride as a diluent. The 50 mg/50 mL strength means that each vial or bag contains 50 mg of argatroban in 50 mL of sodium chloride solution. It is administered intravenously (IV) and prescribed by a doctor or healthcare provider for therapeutic purposes.

Fast, Reliable Anticoagulation: Argatroban in Sodium Chloride Injection 50 mg/50 mL by Eugia US

For healthcare providers demanding precision and safety in anticoagulation therapy, Argatroban in Sodium Chloride Injection 50 mg/50 mL by Eugia US (NDC: 55150-0241-01) delivers effective, FDA-approved direct thrombin inhibition in a convenient, ready-to-use formulation. This hospital-standard solution is crucial in managing patients with heparin-induced thrombocytopenia (HIT) and during procedures requiring acute anticoagulation.

Uses

• Heparin-Induced Thrombocytopenia (HIT): Indicated for both the prophylaxis and treatment of thrombosis in adult patients with HIT.
• Percutaneous Coronary Intervention (PCI): Provides anticoagulation in patients with or at risk for HIT undergoing PCI.
• Alternative Anticoagulation: Used when heparin or low molecular weight heparins are contraindicated.

Benefits

• Ready-to-Use Injection: Pre-mixed formulation in 0.9% sodium chloride ensures convenience, sterility, and dosing accuracy.
• Rapid Onset & Reliable Control: Begins anticoagulation effects quickly, ideal for acute and critical care settings.
• No Cross-reactivity with Heparin: Safe for use in patients with heparin allergies or HIT.
• Manufactured by Eugia US: Trusted pharmaceutical quality and strict adherence to safety standards.
• Minimizes Medication Errors: Reduces compounding time and contamination risks associated with manual preparation.

Specifications

Directions

For hospital and professional healthcare use only.

1. Preparation:
   • The solution is premixed and ready for IV administration; do not dilute further.
2. Administration:
   • Administer as a continuous IV infusion using a calibrated infusion device.
   • Initiate therapy at the recommended initial rate (typically 2 mcg/kg/min), adjust according to activated partial thromboplastin time (aPTT) or per physician protocol.
   • For PCI, follow specific dosing and monitoring instructions as outlined in product literature.
3. Monitoring:
   • Regularly monitor aPTT or ACT to ensure therapeutic levels and adjust dose as needed.
4. Use Immediately:
   • Discard unused portion after single patient use.

Always follow institutional protocols and the prescribing healthcare provider’s instructions for dosing and adjustments.

Side Effects

Common Side Effects:

• Bleeding or hematoma at the infusion site
• Hypotension
• Nausea or vomiting
• Fever
• Dyspnea

Serious/Rare Side Effects:

• Severe bleeding (gastrointestinal, intracranial, or other sites)
• Allergic reactions (rash, itching, anaphylaxis)
• Liver enzyme elevation

Seek immediate medical attention for signs of excessive bleeding, severe dizziness, shortness of breath, or allergic reactions.

Warnings

• Risk of Bleeding: Argatroban increases the risk of bleeding in all settings; monitor closely and adjust dosage as required.
• Hepatic Impairment: Reduce dose in patients with liver dysfunction and monitor more frequently due to increased exposure.
• Drug Interactions: Caution with concomitant use of other anticoagulants, antiplatelet agents, or thrombolytics.
• Not for IM or SC Use: For intravenous administration only.
• Pregnancy/Breastfeeding: Use only if clearly needed and prescribed by a physician.
• Pediatric Use: Safety and efficacy not established in children.

Why Choose Argatroban in Sodium Chloride Injection by Eugia US?

Argatroban in Sodium Chloride Injection 50 mg/50 mL by Eugia US (NDC: 55150-0241-01) meets clinical demands for rapid, precise, and safe anticoagulation. The ready-to-use, pre-mixed vial minimizes preparation errors and maximizes efficiency in acute and emergency care, making it the preferred choice among hospitals and clinicians for treating HIT and supporting PCI procedures.

Order Argatroban in Sodium Chloride Injection 50 mg/50 mL by Eugia US today for dependable, immediate anticoagulant therapy.